Home > Media Center > News > Gornitzky represented Strauss Group Ltd. in preparing a Shelf Prospectus.

May 27, 2019

Gornitzky represented Strauss Group Ltd. in preparing a Shelf Prospectus.

Gornitzky represented Strauss Group Ltd. in preparing a Shelf Prospectus and receiving approval of TASE for the registration of the Securities for trade on TASE.
Strauss Group Ltd. was represented by partner Sharon Werker-Sagy associate Sharon Strauss.

RELATED NEWS & PUBLICATIONS

All Publications

News

Gornitzky represented Jefferies in the USD 10 million follow-on offering of Sol-Gel Technologies Ltd. on the NASDAQ Global Market.

News

Gornitzky represented the underwriters, led by Barclays and UBS, in the USD 70 million IPO of InMode Ltd.

News

Gornitzky represented O.P.C. Energy in capital raising of approximately NIS 120 million.

News

Gornitzky represented the underwriters, led by Ladenburg Thalmann, in Pluristem Therapeutics’ underwritten public offering and concurrent registered direct offering, raising USD 21 million.

All Publications

Gornitzky represented Strauss Group Ltd. in preparing a Shelf Prospectus.

KEY CONTACTS

Sharon Werker-Sagy

Sharon Strauss

RELATED PRACTICES

RELATED NEWS & PUBLICATIONS

Gornitzky represented Jefferies in the USD 10 million follow-on offering of Sol-Gel Technologies Ltd. on the NASDAQ Global Market.

Gornitzky represented the underwriters, led by Barclays and UBS, in the USD 70 million IPO of InMode Ltd.

Gornitzky represented O.P.C. Energy in capital raising of approximately NIS 120 million.

Gornitzky represented the underwriters, led by Ladenburg Thalmann, in Pluristem Therapeutics’ underwritten public offering and concurrent registered direct offering, raising USD 21 million.

Gornitzky represented Melisron Ltd. in its NIS 260 million public offering of bonds on the TASE.

Gornitzky represented Melisron Ltd. in its NIS 220 million public offering of bonds on the TASE.

Gornitzky represented Israel Ports Development & Assets Company Ltd., in the issuance of commercial securities in a total scope of NIS 400 million

Gornitzky represented the underwriters, led by Oppenheimer & Co., in the USD 15.4 million follow-on offering of BioLineRx Ltd.

Gornitzky represented the underwriters, led by Goldman Sachs, J.P. Morgan and Jefferies, in the USD 172.5 million follow-on offering of UroGen Pharma Ltd.

Client Update: New prohibition on offering to Israeli investors trading services of securities traded on foreign exchanges without a permit from the Israel Securities Authority.

Gornitzky represented the underwriters in RedHill Biopharma’s USD 20 million public offering.

Gornitzky represented PetroTex Limited Partnership in its NIS 50 million public offering of secured bonds, and in its purchase of petroleum assets in Mississippi USA.